Android app on Google Play

Vivus (VVUS) Surges as Qsymia Prescriptions Rise 46%

December 17, 2012 9:46 AM EST Send to a Friend
Get Alerts VVUS Hot Sheet
Price: $4.25 +2.16%

Rating Summary:
    4 Buy, 7 Hold, 5 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 21 | Down: 25 | New: 14
Trade VVUS Now!
Join SI Premium – FREE
Vivus, Inc. (NASDAQ: VVUS) is stronger early Monday following positive script data.

Analysts at Bloomberg Industries noted that Qsymia prescriptions gained 46% week-over-week, citing data from Symphony Health Solutions.

Shares of Vivus last traded at $12.55, up 9.3 percent.




You May Also Be Interested In


Related Categories

Analyst Comments, FDA, Trader Talk

Add Your Comment